Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Inovio Pharmaceuticals, Inc. INO
$0.71
-$0.07 (-9.79%)
На 18:00, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
211925284.00000000
-
week52high
2.82
-
week52low
0.69
-
Revenue
10262268
-
P/E TTM
0
-
Beta
1.06678200
-
EPS
-1.23000000
-
Last Dividend
0.27600000
-
Next Earnings Date
10 мая 2023 г. в 20:00
Описание компании
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers, including cervical, vulvar, and anal dysplasia; HPV-associated cancers, such as head and neck, cervical, anal, penile, vulvar, and vaginal; other HPV-associated disorders, including recurrent respiratory papillomatosis; glioblastoma multiforme; prostate cancer; HIV; Ebola; Middle East Respiratory Syndrome (MERS); and Lassa fever. Its partners and collaborators include ApolloBio Corp., AstraZeneca, Beijing Advaccine Biotechnology Co., Ltd., The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations (CEPI), Defense Advanced Research Projects Agency (DARPA), Department of Defense (DoD), HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, Medical CBRN Defense Consortium (MCDC), National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Ology Bioservices, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Thermo Fisher Scientific, University of Pennsylvania, Walter Reed Army Institute of Research, and The Wistar Institute. The company has an agreement with Richter-Helm BioLogics GmbH & Co. KG to support investigational DNA vaccine INO-4800 for COVID-19; and a partnership with International Vaccine Institute and Seoul National University Hospital. The company was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| RBC Capital | Sector Perform | Sector Perform | 10 авг 2022 г. |
| Oppenheimer | Perform | Outperform | 11 мая 2022 г. |
| RBC Capital | Sector Perform | Sector Perform | 02 мар 2022 г. |
| B of A Securities | Neutral | Underperform | 21 янв 2022 г. |
| RBC Capital | Sector Perform | Sector Perform | 01 ноя 2021 г. |
| B of A Securities | Underperform | Neutral | 01 ноя 2022 г. |
| Maxim Group | Hold | Buy | 09 ноя 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Shepard Jay | D | 0 | 4273 | 15 янв 2023 г. |
| Shepard Jay | A | 39521 | 4273 | 15 янв 2023 г. |
| Weiner David B. | D | 11875 | 11875 | 11 авг 2022 г. |
| Weiner David B. | D | 892625 | 11875 | 11 авг 2022 г. |
| Weiner David B. | A | 904500 | 11875 | 11 авг 2022 г. |
| BENITO SIMON X | D | 4000 | 2000 | 20 июл 2022 г. |
| BENITO SIMON X | D | 75305 | 2000 | 20 июл 2022 г. |
| BENITO SIMON X | A | 77305 | 2000 | 20 июл 2022 г. |
| Sumner Michael John | A | 105000 | 105000 | 30 июн 2022 г. |
| Sumner Michael John | A | 160000 | 160000 | 30 июн 2022 г. |
Новостная лента
Inovio Pharmaceuticals (INO) Reports Q1 Loss, Misses Revenue Estimates
Zacks Investment Research
10 мая 2023 г. в 18:59
Inovio Pharmaceuticals (INO) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to loss of $0.36 per share a year ago.
Penny Stocks To Buy? 10 Under $1 To Watch This Week
PennyStocks
19 апр 2023 г. в 15:29
Penny stocks under $1 to watch this week. The post Penny Stocks To Buy?
These 3 Nasdaq Stocks Are on Fire Today: Here's Why
The Motley Fool
17 апр 2023 г. в 13:55
Merck's decision to pay top dollar for a late-stage asset is sparking a wave of bargain buying in biotech today. Agenus, Inovio Pharmaceuticals, and Roivant Sciences are three of the biggest beneficiaries of the industrywide trend.
Penny Stocks To Buy? 7 Under $1 To Watch This Week
PennyStocks
17 апр 2023 г. в 11:15
Penny stocks to watch trading for pennies this week. The post Penny Stocks To Buy?
Why Inovio Pharmaceuticals' Shares Jumped on Thursday
The Motley Fool
13 апр 2023 г. в 14:07
Inovio's shares are down more than 43% this year. The company said it has enough cash to last into the first quarter of 2025.